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Nutrition in children posttransplantation
Introduction
Transplantation in children differs in some aspects of perioperative 
and posttransplant care from adult transplantation because of 
differences in the aetiology of the primary underlying disease, patient 
size, immunologic responsiveness, medication pharmokinetics as 
well as growth and development issues.
There is little data looking at nutrition posttransplantation in children. 
Improvement in growth should occur postoperatively. Factors 
associated with continued poor growth include age at transplantation, 
malnutrition, surgical complications of the transplant, allograft 
dysfunction and excessive corticosteroid use.
The nutritional goal in the immediate postoperative period is to 
provide adequate nutrition to “catch up” the pretransplant nutritional 
deficit associated with a chronic liver disease and to allow for 
recovery from major surgery.
Early oral or enteral feeding should be strived for after successful 
uncomplicated heart, liver and kidney transplantation. Aggressive 
early posttransplant nutritional therapy facilitates wound healing, 
decreases infectious complications and shortens ventilation time. 
Parenteral nutrition is needed if there is prolonged postoperative 
ileus or if gastrointestinal complications of surgery limit enteral 
feeding.
All transplant patients require nutritional follow up to assess nutritional 
status and to detect, prevent and treat late-onset complications such 
as obesity, hyperglycaemic hyperlipidaemia or osteoporosis. Dietetic 
support is an essential component of the transplant team. Although 
this manuscript focuses on the nutritional care of the paediatric 
patient post liver transplantation, most aspects of the management 
is relevant to a patient undergoing any solid organ transplant. 
Aspects of care specific to renal or intestinal transplantation will also 
be addressed.
LIVER 
Children with chronic liver disease (CLD) are at high risk for 
malnutrition, especially when the disease is cholestatic in nature and 
its onset is in infancy. The most common CLD in our setting requiring 
transplantation in childhood is biliary atresia (70% of cases). 
Malnutrition is a manifestation of decompensated liver disease. Liver 
transplantation is a complex procedure that is performed in children 
who often have multiple co-morbidities.
Growth retardation and malnutrition are common complications of 
CLD because of decreased intake, malabsorption and relative growth 
hormone resistance. Nutritional support is complicated by increased 
energy expenditure, malabsorption secondary to gut oedema, 
cholestasis and poor intake. Cholestasis leads to malabsorption of 
fat soluble vitamins. Managing malnutrition in children in with end 
stage liver disease is a challenge.
Pretransplant nutritional therapy
In children with end-stage liver disease (ESLD) the nutritional goal 
is to maintain maximum growth potential, prevent further liver 
injury, promote liver regeneration, minimise risk of infection and 
avoid vitamin and mineral deficiencies.1 They require 130–150% 
of the recommended dietary allowances (RDA) of energy for their 
ideal body weight. About 60–70% of the energy should be given as 
high complex and simple carbohydrates. The later should be limited 
when glucose intolerance is present. The other 30–40% of energy 
are provided by fat with some as medium chain triglycerides, if fat 
malabsorption is present. Long chain triglycerides should not be 
decreased to less than 10% of the total energy intake to prevent 
deficiencies in essential fatty acids. The RDA of protein for children 
with CLD is 2.5–3.0 g/Kg of ideal body weight because of their 
catabolic state and the need to improve growth rate.2 Branched 
chain amino acids (BCAA) (leucine, isoleucine and valine) improve 
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hepatic protein synthesis. Most formulas contain between 16–53% 
BCAA. If the patient is encephalopathic the protein may need to be 
decreased (1.0–1.5g/Kg) and the more expensive formulas with a 
high content of BCAA may be considered.
Nasogastric tube feeds may be required in children with advanced 
liver disease who are unable to take sufficient feeds orally. If 
continuous nasogastric feeds become necessary it is important to 
continue small amounts of oral feeds so that the infants do not lose 
feeding skills after transplantation.
Patients awaiting orthotopic liver transplantations should take a 
daily multivitamin, as well as fat soluble vitamin supplementation 
including additional vitamin D as needed together with folic acid, 
zinc and magnesium. 
Posttransplant nutritional therapy
Early postoperative period
The nutritional goal in the immediate postoperative period (two 
months) is to provide adequate nutrition to correct the pretransplant 
nutritional deficit associated with chronic liver disease and to allow 
for the additional stress of major abdominal surgery.
Preoperative malnutrition, stress of the surgical procedure, 
immunosuppressive therapy, liver or kidney dysfunction or sepsis 
are all factors that contribute to a persistent catabolic state in the 
early posttransplant period.
Early use (within the first 24–36 hours) of enteral feeding is 
recommended post an uncomplicated liver transplant, once the 
postoperative ileus has resolved.3 This is usually done using 
continuous nasogastric feeding of a polymeric feed. If this is not 
tolerated then use of a semi-elemental feed would be considered. 
When the patient begins to eat solid food, enteral feeding can be 
used as overnight feeds to enhance the appetite during the day. 
The oral intake can be changed to a regular diet as tolerated, and 
once there is adequate oral intake the enteral feeds can be stopped. 
In this period the patients have a high protein, high energy diet to 
counteract the weight loss associated with pretransplant cachexia. 
Patients are often not advised when to wean off this diet. Parental 
nutrition is needed if there is a prolonged postoperative ileus or 
gastrointestinal complications. Chylous ascites may be related to 
lymphatic disruption and responds to fat restricted diet.
Although liver transplantation allows resolution of metabolic 
dysfunction PEM and nutritional deficiencies, the need for nutrition 
monitoring and therapy continues. Patients who are not malnourished 
and who can eat within a few days of the transplant may not need 
post-op nutrition support.
Metabolic/electrolytes
Routine posttransplant care includes monitoring fluid balance 
carefully with strict intake and output measurements and daily body 
weight measurements. Many laboratory tests are monitored which 
include full blood count, differential and clotting, blood glucose, 
electrolytes, calcium, phosphorus, magnesium, albumin and 
liver enzymes. Electrolyte abnormalities are common in the early 
posttransplant period. Sodium can be lost in the urine, nasogastric 
tube losses, and abdominal drains. Serum potassium, phosphate and 
magnesium levels can deplete early post liver transplant due to the 
use of diuretics and the refeeding syndrome. Cyclosporin, tacrolimus 
and kidney insufficiency can cause hyperkalaemia. Cyclosporin can 
accelerate magnesium losses.
All children routinely receive multivitamin supplements. In the long 
term the transplant recipient should only receive dietary supplements, 
if indicated. 
Long-term posttransplant nutritional therapy
The diet of the liver transplant recipient should be monitored for 
energy and protein intakes for the first 2–3 years posttransplantation 
to maximise growth and to prevent obesity and its complications.
Obesity 
A major problem in the transplant recipient is long-term excess 
energy and fat intake with excessive weight gain leading to 
overweight and obesity. The side effects most often seen with over-
nutrition would include hypertension, diabetes mellitus and altered 
blood lipids. Once the pretransplant loss of weight and muscle has 
been regained there must be careful nutritional monitoring to prevent 
excessive weight gain. Weight gain is most dramatic between 
two and 16 months after transplantation. In a study of adult liver 
recipients, 43% were obese 18 months after transplant and a further 
24% were overweight.4 The causes of weight gain are multifactorial, 
the appetite is definitely stimulated by corticosteroids and often the 
patients are quite sedentary. 
Patients and their families need to be educated about posttransplant 
obesity and its risks. It is important to monitor weight gain and to 
make aggressive efforts to decrease high fat foods for children who 
are gaining weight excessively. Most of the weight gained after 
transplantation is fat. Muscle mass is not always regained. A diet 
low in saturated fat and high in fibre and vegetables together with 
regular aerobic and weight bearing exercise has been shown to 
have a major role in preventing weight gain and lowering lipid levels 
posttransplant. Dietary support by the dietitian is crucial.
Growth retardation
Many children, particularly those with cholestatic disease, have 
growth retardation before liver transplantation, because of decreased 
intake, malabsorption and relative growth hormone resistance. 
Generally transplanted children do not have complete catch up 
growth and achieve a final height below their genetic potential.5,6 A 
recent study found that after liver transplantation in childhood, 50% 
of patients reached a final height lower than -1.3SD of their genetic 
potential.5 Ng et al found that 73% of recipients were below average 
height five years post liver transplantation.6 The growth delay in 
children after transplantation is often attributed to corticosteroid use 
but this is not the only factor. However, excessive corticosteroid use 
must be avoided.
Diabetes mellitus
The occurrence of diabetes mellitus (DM) in transplant recipients is 
significantly increased when compared with the general population. 
The real incidence in posttransplant DM in children is unknown. In 
small retrospective studies it is reported to be between two and 
24%.7 In an audit at Red Cross Children’s Hospital the incidence in 
liver and kidney transplants was 6%. The high risk factors in our 
group were black patients (50%), tacrolimus, high dose steroids 
and overweight. Many children can be weaned off insulin during 
follow up.
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New onset diabetes mellitus is a known side effect of both 
glucocorticosteroids and the calcineurin inhibitors because these 
drugs affect insulin secretion and tissue sensitivity or resistance to 
the effects of insulin. Age, family history, African ethnicity and use of 
tacrolimus are all risk factors for a higher incidence of diabetes in 
transplant patients.
Metabolic bone disease
The adverse effects on bone that occur posttransplantation include 
osteoporosis/bone loss, fractures and avascular necrosis. Most 
liver transplant recipients lose bone mass for 3–6 months after 
transplantation. In patients with a normally functioning graft this 
bone loss stops after six months.1 Adequate treatment with calcium 
and vitamin D in the pre- and posttransplantation periods along 
with physical activity is important to decrease the complications of 
metabolic bone disease.
Immunosuppression
Most paediatric liver transplant recipients are initially treated with a 
triple immmunosuppression regimen. The side effects of the more 
common immunosuppressive agents (Table I) together with the more 
common drugs and foods that affect the levels of the calcineurin 
inhibitors (cyclosporine and tacrolimus) (Table II) should always be 
brought in mind. 
RENAL
Meticulous fluid and electrolyte management is important in the 
paediatric renal transplant patient because such patients often need 
additional intravascular volume repletion in the perioperative period 
to establish diuresis and avoid delayed 
graft function. This is critical if a small 
child has received an adult graft.
There is little data on dietary recom-
mendations for children following renal 
transplantation. Energy and protein 
needs are increased immediately 
after transplant. Protein needs are 
150–200% of the recommended daily 
allowance (RDA) for age and weight. 
It is important to meet these needs to 
achieve wound healing to help prevent 
muscle wasting associated with high 
dose steroids. Supplemental enteral 
or parenteral nutrition is indicated 
in patients who cannot meet their 
energy and nutrient requirements 
via oral intake in the first few days 
posttransplant.
INTESTINAL
The outcome after intestinal trans-
plantation has improved over the past 
decade. The postoperative management 
after liver transplantation is the most 
challenging of all the solid organ 
transplants. Total parenteral nutrition 
(TPN) is required for the first 3–6 weeks 
after transplantation. Continuous 
small volume (2 to 5 ml/hr) of enteral 
feeding is usually started within 10 days of the transplant. Elemental 
enteral formulae are used. The choice of enteral diet depends on 
age, previous diets and previous sensitisations. Posttransplant fat 
malabsorption can occur secondary to the severance of lymphatic 
channels of the intestinal graft.8
Once enteral feeding is established, the TPN is decreased. TPN is 
usually maintained until 70% of nutritional requirements are tolerated 
enterally. When the child is stable and tolerating enteral feeds, solid 
food is introduced according to the child’s age and preference. 
Chronically ill infants and children who are at risk for oral aversion 
enteral tube feeding is necessary for many months. The transition to 
full oral intake may take years and in some cases is never achieved. 
Development of food allergies is common so initial avoidance of milk 
and eggs from the diet is recommended.
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Table I: Side effects of immunosuppressive agents
Corticosteroids:
Growth retardation


























* Nutritional side effects are in bold
Table II: Medications that alter calcineurin 
(CNI) levels























Medications that increase renal toxicity:
Vancomycin
Aminoglycosides
Bactrim
Aciclovir
Ganciclovir
Amphotericin
